Centogene N.V.
CNTGNASDAQHealthcare
$0.33
+$0.33(+100.00%)
Market Cap$9419082
P/E Ratio—
52W High$0.429
52W Low$0.325
Centogene N.V. (CNTG) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CNTG · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $48.54M | $47.47M | $42.23M | $38.45M | $48.78M |
| Cost of Revenue | $31.29M | $27.55M | $27.67M | $35.29M | $26.00M |
| Gross Profit | $17.25M | $19.92M | $14.57M | $3.17M | $22.77M |
| Gross Margin %(computed) | 35.54% | 41.96% | 34.49% | 8.24% | 46.69% |
| Operating Expenses | |||||
| R&D Expenses | $12.36M | $17.49M | $19.30M | $14.94M | $9.59M |
| G&A Expenses | $29.17M | $29.21M | $43.48M | $37.66M | $23.16M |
| Total Operating Expenses | $46.91M | $56.53M | $72.98M | $60.18M | $42.11M |
| Operating Income | ($29.66M) | ($36.77M) | ($55.49M) | ($53.73M) | ($19.34M) |
| Operating Margin %(computed) | -61.11% | -77.46% | -131.38% | -139.73% | -39.64% |
| Interest Income | $0.20M | $0.00M | $0.00M | $0.03M | $0.02M |
| Interest Expense | $8.20M | $3.57M | $0.80M | $1.04M | $2.03M |
| Income Before Tax | ($35.24M) | ($38.60M) | ($57.42M) | ($59.81M) | ($20.70M) |
| Income Tax Expense | $0.29M | $0.11M | ($0.07M) | $0.22M | $0.16M |
| Net Income | ($35.53M) | ($31.84M) | ($46.25M) | ($21.38M) | ($20.86M) |
| Net Margin %(computed) | -73.21% | -67.07% | -109.50% | -55.60% | -42.75% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.27 | $-1.11 | $-2.09 | $-1.02 | $-1.27 |
| Wtd Avg Shares | 28.16M | 26.81M | 22.44M | 20.91M | 16.41M |
| EBITDA | ($19.43M) | ($24.65M) | ($36.65M) | ($43.67M) | ($12.09M) |
| EBITDA Margin %(computed) | -40.04% | -51.92% | -86.77% | -113.56% | -24.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M
Explore more Centogene N.V. data
About Centogene N.V. (CNTG) Income Statement
Centogene N.V. (CNTG) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, CNTG reported revenue of $0.05B, gross profit of $0.02B (gross margin 35.54%), and net income of ($0.04B) — a net profit margin of -73.21%.
Frequently asked questions
CNTG · 4 questionsCentogene N.V. (CNTG) reported revenue of $0.05B for 2023, up 2.2% year-over-year.
CNTG revenueCNTG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09